Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2000
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162811 Antitumor agents
12/19/2000US6162804 Tyrosine kinase inhibitors
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/19/2000US6162417 Radioactive halogen-substituted 6-(phenyl)pyrrolo(2,1-a)-isoquinolines; binding to serotonin transporter ligands; tomography imaging, diagnosis/treatment of psychiatric disorders, e.g., obsesive-compulsive; antidepressant; anxiety
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/14/2000WO2000075236A1 Extended rhodamine compounds useful as fluorescent labels
12/14/2000WO2000075145A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000WO2000075141A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000074679A1 Substituted piperidines as melanocortin-4 receptor agonists
12/14/2000WO2000063208B1 Substituted imidazoles, their preparation and use
12/14/2000WO2000047568A3 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
12/14/2000WO2000046225A3 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2377369A1 Substituted piperidines as melanocortin-4 receptor agonists
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2365075A1 Extended rhodamine compounds useful as fluorescent labels
12/13/2000EP1058684A1 Glycine transport inhibitors
12/13/2000EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS
12/13/2000EP0724583B1 Pyridazino quinoline compounds
12/13/2000CN1276790A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them
12/13/2000CN1276370A Process for preparing anticancer compound, and intermediate
12/13/2000CN1059442C Use of 1,2-bridged 1,4-dihydropyridines as medicaments
12/12/2000US6159967 such as 1-(2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl) morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1-(3H), 4'-piperidine)-(2S)-oxide; respiratory disease such as asthma
12/07/2000WO2000073305A1 Preparation of camptothecin and nothapodytine derivatives
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073274A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000072846A1 Antibacterial compounds
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375630A1 Antibacterial compounds
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375188A1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2340012A1 Preparation of camptothecin and nothapodytine derivatives
12/06/2000EP1057828A2 Trovafloxacin oral suspensions
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1057819A1 Phthalazine derivatives and remedies for erectile dysfunction
12/06/2000EP1057814A1 Tetrahydrobenzindole derivatives
12/06/2000EP1057484A1 Cell death inhibitors
12/06/2000EP1056717A1 Arylphenyl-substituted cyclic keto-enols
12/06/2000CN1275982A Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
12/06/2000CN1275571A Technology for preparing oxymatrine from sophora alopecuroide
12/05/2000US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
12/05/2000US6156902 Bis-o-amino (thio) phenols, and their preparation
12/05/2000US6156901 Spiro[cyclopent[b]indole-piperidines]
12/05/2000US6156897 Method for purifying 20(S)-camptothecin
12/05/2000US6156766 Heterocyclic benzamides as drugs
12/05/2000US6156763 Enzyme inhibitors with heterocyclic diimides
12/05/2000US6156747 Psychological, gastrointestinal, cardiovascular disorders
12/04/2000CA2311112A1 Trovafloxacin oral suspensions
11/2000
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071541A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071524A1 2-nh-pyridones and pyrimidones as mrs inhibitors
11/30/2000WO2000071502A1 Hydrazide derivatives
11/30/2000WO2000071102A2 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/30/2000WO2000044379A3 Methods for restoring and/or enhancing accommodation in pseudo phakia
11/30/2000DE19924819A1 Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) Substituted Phenylcyclohexancarbonsäurebenzylamid (adenosine uptake inhibitors)
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2369746A1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/29/2000EP1055672A1 1,4-dihydropyridine derivatives
11/29/2000EP1054889A1 New oxazolidinones with azol-containing tricycles
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054859A1 Processes and intermediates useful to make antifolates
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000CN1275124A Phthalazine derivatives and remedies for erectile dysfunction
11/29/2000CN1274724A Prepn. of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-asymmetric indacene
11/29/2000CN1058969C Novel substd. guanidine derivs, process for prodn. thereof, and pharmaceutical uses thereof
11/29/2000CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture
11/29/2000CN1058967C Novel pyridine compounds, processes for their preparation and pharmaceutical compositions thereof
11/28/2000US6153617 Used for reating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
11/28/2000US6153608 Isoquinoline derivatives and drugs
11/28/2000US6153414 Method for racemic biochemical resolution of CIS-and trans-pyprolopiperidine
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/23/2000WO2000069862A2 Hemisynthetic method and intermediates thereof
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069857A1 Process for making fused-ring imidazo-containing compounds
11/23/2000WO2000069856A1 Compounds and therapeutic methods
11/23/2000WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069464A1 Novel use
11/23/2000CA2373509A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372469A1 Process for making fused-ring imidazo-containing compounds
11/23/2000CA2372051A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000CA2372032A1 Compounds and therapeutic methods
11/22/2000EP1053246A1 Beta-sheet mimetics and methods relating to the use thereof
11/22/2000EP1053237A2 Inhibition of human telomerase by a g-quadruplex-interaction compound
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 646